" class="no-js "lang="en-US"> Companies Archive - Page 12 of 145 - Medtech Alert
Tuesday, September 16, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 CytoReason | Pharmtech Focus

CytoReason

View Company

 STADA | Pharmtech Focus

STADA

View Company

 Calliditas Therapeutics | Pharmtech Focus

Calliditas Therapeutics

View Company

 jCyte | Pharmtech Focus

jCyte

View Company

 Avectas | Pharmtech Focus

Avectas

View Company

 Hadassah University Medical Center | Pharmtech Focus

Hadassah Medical Center

View Company

 Advanced NanoTherapies

Advanced NanoTherapies

View Company

 Versantis | Pharmtech Focus

Versantis

View Company

 Swiss Biotech Versantis | Pharmtech Focus

Swiss Biotech

View Company

London Medical Laboratory

Load More Results